| PERIOD ENDING | 31-Aug-09 | 31-May-09 | 28-Feb-09 | 30-Nov-08 | | Total Revenue | 183,633 | 174,388 | 166,221 | 165,333 | | Cost of Revenue | 28,441 | 26,468 | 25,653 | 26,536 | | | Gross Profit | 155,192 | 147,920 | 140,568 | 138,797 | | | Operating Expenses | | Research Development | 36,360 | 35,102 | 34,993 | 34,545 | | Selling General and Administrative | 91,291 | 87,762 | 85,338 | 83,282 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 27,541 | 25,056 | 20,237 | 20,970 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 5,760 | 3,480 | 5,216 | 13,795 | | Earnings Before Interest And Taxes | 33,301 | 28,536 | 25,453 | 34,765 | | Interest Expense | 43 | 53 | 433 | 1,249 | | Income Before Tax | 33,258 | 28,483 | 25,020 | 33,516 | | Income Tax Expense | 4,321 | 9,969 | 9,032 | 9,211 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 28,937 | 18,514 | 15,988 | 24,305 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 28,937 | 18,514 | 15,988 | 24,305 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $28,937 | $18,514 | $15,988 | $24,305 |
|
0.28% Nasdaq 
Income Statement
